Cargando…
New Drug Development and Clinical Trial Design by Applying Genomic Information Management
Depending on the patients’ genotype, the same drug may have different efficacies or side effects. With the cost of genomic analysis decreasing and reliability of analysis methods improving, vast amount of genomic information has been made available. Several studies in pharmacology have been based on...
Autores principales: | Ko, Young Kyung, Gim, Jeong-An |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330622/ https://www.ncbi.nlm.nih.gov/pubmed/35893795 http://dx.doi.org/10.3390/pharmaceutics14081539 |
Ejemplares similares
-
A Genomic Information Management System for Maintaining Healthy Genomic States and Application of Genomic Big Data in Clinical Research
por: Gim, Jeong-An
Publicado: (2022) -
DNA Methylation Patterns According to Fatty Liver Index and Longitudinal Changes from the Korean Genome and Epidemiology Study (KoGES)
por: Ko, Young Kyung, et al.
Publicado: (2022) -
Use of Real‐World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design
por: Dagenais, Simon, et al.
Publicado: (2021) -
DNA Methylation Profiling for the Diagnosis and Prognosis of Patients with Nontuberculous Mycobacterium Lung Disease
por: Oh, Jee Youn, et al.
Publicado: (2021) -
Applying Probabilistic Decision Models to Clinical Trial Design
por: Smith, Wade P, et al.
Publicado: (2018)